PIK3C3 and neoplasm: However, taking into consideration that autophagy also participates in the evasion of tumor cells from immune surveillance, the interest of targeting VPS34 in the field of cancer immunotherapy is reinforced (Mgrditchian et al., 2017; Noman et al., 2020).